ATE58554T1 - Menschlicher hybridomfusionspartner zur herstellung menschlicher monoklonaler antikoerper. - Google Patents
Menschlicher hybridomfusionspartner zur herstellung menschlicher monoklonaler antikoerper.Info
- Publication number
- ATE58554T1 ATE58554T1 AT85306493T AT85306493T ATE58554T1 AT E58554 T1 ATE58554 T1 AT E58554T1 AT 85306493 T AT85306493 T AT 85306493T AT 85306493 T AT85306493 T AT 85306493T AT E58554 T1 ATE58554 T1 AT E58554T1
- Authority
- AT
- Austria
- Prior art keywords
- human
- hybridom
- production
- monoclonal antibodies
- fusion partner
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- C12N5/12—Fused cells, e.g. hybridomas
- C12N5/16—Animal cells
- C12N5/163—Animal cells one of the fusion partners being a B or a T lymphocyte
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/948—Microorganisms using viruses or cell lines
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/673,370 US4693975A (en) | 1984-11-20 | 1984-11-20 | Human hybridroma fusion partner for production of human monoclonal antibodies |
EP85306493A EP0182467B1 (de) | 1984-11-20 | 1985-09-12 | Menschlicher Hybridomfusionspartner zur Herstellung menschlicher monoklonaler Antikörper |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE58554T1 true ATE58554T1 (de) | 1990-12-15 |
Family
ID=24702377
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT85306493T ATE58554T1 (de) | 1984-11-20 | 1985-09-12 | Menschlicher hybridomfusionspartner zur herstellung menschlicher monoklonaler antikoerper. |
Country Status (7)
Country | Link |
---|---|
US (1) | US4693975A (de) |
EP (1) | EP0182467B1 (de) |
JP (1) | JPS61128886A (de) |
AT (1) | ATE58554T1 (de) |
AU (1) | AU577745B2 (de) |
CA (1) | CA1245581A (de) |
DE (1) | DE3580654D1 (de) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1214123A (en) * | 1983-01-20 | 1986-11-18 | Masashi Matsui | Cell lines for use in the preparation of hybridoma cells |
JPH0798000B2 (ja) * | 1987-05-23 | 1995-10-25 | 萩原 義秀 | ガン関連抗原特異的ヒト免疫グロブリン |
US5001065A (en) * | 1987-05-27 | 1991-03-19 | Cetus Corporation | Human cell line and triomas, antibodies, and transformants derived therefrom |
JPH0249597A (ja) * | 1988-04-27 | 1990-02-19 | Kimiyoshi Tsuji | モノクローナル抗体及びその利用方法 |
CA2002067A1 (en) * | 1988-11-09 | 1990-05-09 | Tamotsu Fukuda | Parent cell line for producing human hybridomas |
US6274552B1 (en) | 1993-03-18 | 2001-08-14 | Cytimmune Sciences, Inc. | Composition and method for delivery of biologically-active factors |
US20010055581A1 (en) * | 1994-03-18 | 2001-12-27 | Lawrence Tamarkin | Composition and method for delivery of biologically-active factors |
US7229841B2 (en) * | 2001-04-30 | 2007-06-12 | Cytimmune Sciences, Inc. | Colloidal metal compositions and methods |
US6407218B1 (en) | 1997-11-10 | 2002-06-18 | Cytimmune Sciences, Inc. | Method and compositions for enhancing immune response and for the production of in vitro mabs |
JP2008504216A (ja) * | 2003-12-02 | 2008-02-14 | サイトイミューン サイエンシズ インコーポレイテッド | モノクローナル抗体の生成のための方法および組成物 |
AU2005209318B2 (en) * | 2004-01-28 | 2010-02-11 | Cytimmune Sciences, Inc. | Functionalized colloidal metal compositions and methods |
CN102533966B (zh) | 2005-08-01 | 2014-03-12 | 俄亥俄州立大学研究基金会 | 用于乳腺癌的诊断、预后和治疗的基于MicroRNA的方法和组合物 |
JP2009507918A (ja) | 2005-09-12 | 2009-02-26 | ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション | Bcl2関連癌の診断及び療法のための組成物及び方法 |
EP2502630B1 (de) | 2006-01-05 | 2015-03-11 | The Ohio State University Research Foundation | Verfahren und Zusammensetzungen auf Mikro-RNA-Basis zur Diagnose, Prognose und Behandlung von Lungenkrebs |
AU2007205257B2 (en) | 2006-01-05 | 2013-07-25 | The Ohio State University Research Foundation | MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors |
ES2545119T3 (es) | 2006-01-05 | 2015-09-08 | The Ohio State University Research Foundation | Métodos basados en microARN y composiciones para el diagnóstico y el tratamiento de cánceres sólidos |
US7985584B2 (en) | 2006-03-20 | 2011-07-26 | The Ohio State University Research Foundation | MicroRNA fingerprints during human megakaryocytopoiesis |
WO2008008430A2 (en) * | 2006-07-13 | 2008-01-17 | The Ohio State University Research Foundation | Micro-rna-based methods and compositions for the diagnosis and treatment of colon cancer-related diseases |
EP2061907B1 (de) * | 2006-09-19 | 2011-11-23 | The Ohio State University Research Foundation | Tcl1-expression in durch mir-29 und mir-181 regulierter chronischer lymphozyten-leukämie (cll) |
WO2008054828A2 (en) | 2006-11-01 | 2008-05-08 | The Ohio State University Research Foundation | Microrna expression signature for predicting survival and metastases in hepatocellular carcinoma |
EP2109687B1 (de) | 2007-01-31 | 2014-06-04 | The Ohio State University Research Foundation | Micro-rna-basierte verfahren zur behandlung von akuter myeloischer leukämie (aml) |
WO2008153987A2 (en) | 2007-06-08 | 2008-12-18 | The Government Of The United States Of America As Represented By The Secretary Of Department Of Health And Human Services | Methods for determining hepatocellular carcinoma subtype and detecting hepatic cancer stem cells |
CA2690749A1 (en) | 2007-06-15 | 2008-12-24 | The Ohio State University Research Foundation | Oncogenic all-1 fusion proteins for targeting drosha-mediated microrna processing |
WO2009018303A2 (en) | 2007-07-31 | 2009-02-05 | The Ohio State University Research Foundation | Methods for reverting methylation by targeting dnmt3a and dnmt3b |
CN101835902B (zh) | 2007-08-03 | 2014-03-26 | 俄亥俄州立大学研究基金会 | 编码ncrna的超保守区域 |
WO2009020923A1 (en) | 2007-08-03 | 2009-02-12 | Musc Foundation For Research Development | Human monoclonal antibodies and methods for producing the same |
AU2008288806B2 (en) | 2007-08-22 | 2014-11-27 | The Ohio State University Research Foundation | Methods and compositions for inducing deregulation of EphA7 and Erk phosphorylation in human acute leukemias |
US20110014118A1 (en) * | 2007-09-21 | 2011-01-20 | Lawrence Tamarkin | Nanotherapeutic colloidal metal compositions and methods |
US20090104114A1 (en) * | 2007-09-21 | 2009-04-23 | Cytimmune Sciences, Inc. | Nanotherapeutic Colloidal Metal Compositions and Methods |
CN103898069A (zh) | 2007-10-26 | 2014-07-02 | 俄亥俄州立大学研究基金会 | 鉴定脆性组氨酸三联体(Fhit)相互作用的方法及其用途 |
EP2219458B1 (de) * | 2007-11-08 | 2015-07-15 | Cytimmune Sciences, Inc. | Zusammensetzungen und verfahren für die erzeugung von antikörpern |
CN102149827B (zh) | 2008-06-11 | 2014-08-20 | 由卫生与公众服务部代表的***合众国政府 | MiR-26家族作为肝细胞癌和对治疗的应答性的预测性标志物的用途 |
AU2010321555B2 (en) | 2009-11-23 | 2015-10-15 | The Ohio State University | Materials and methods useful for affecting tumor cell growth, migration and invasion |
US8493081B2 (en) * | 2009-12-08 | 2013-07-23 | Magna Closures Inc. | Wide activation angle pinch sensor section and sensor hook-on attachment principle |
CA2816603A1 (en) | 2010-11-12 | 2012-05-18 | The Ohio State University Research Foundation | Materials and methods related to microrna-21, mismatch repair, and colorectal cancer |
AU2011329066B2 (en) | 2010-11-15 | 2017-03-09 | The Ohio State University Research Foundation | Controlled release mucoadhesive systems |
CN103561750A (zh) | 2011-03-07 | 2014-02-05 | 俄亥俄州立大学 | 通过microRNA-155(miR-155)诱导的增变活性使炎症与癌症关联 |
CA2852066A1 (en) | 2011-10-14 | 2013-04-18 | The Ohio State University | Methods and materials related to ovarian cancer |
AU2012352265B2 (en) | 2011-12-13 | 2017-02-16 | Ohio State Innovation Foundation | Methods and compositions related to miR-21 and miR-29a, exosome inhibition, and cancer metastasis |
EP2804960A4 (de) | 2012-01-20 | 2015-08-19 | Univ Ohio State | Brustkrebsbiomarkersignaturen für invasivität und prognose |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2079313A (en) * | 1980-07-07 | 1982-01-20 | Nat Res Dev | Improvements in or relating to rat myeloma cell lines |
CH652145A5 (de) * | 1982-01-22 | 1985-10-31 | Sandoz Ag | Verfahren zur in vitro-herstellung von hybridomen welche humane monoklonale antikoerper erzeugen. |
US4529694A (en) * | 1982-04-16 | 1985-07-16 | The Children's Medical Center Corporation | Cell fusion |
US4574116A (en) * | 1983-01-13 | 1986-03-04 | The Board Of Trustees Of The Leland Stanford Jr. University | Methods and cell lines for immortalization and monoclonal antibody production by antigen-stimulated B-lymphocytes |
CA1214123A (en) * | 1983-01-20 | 1986-11-18 | Masashi Matsui | Cell lines for use in the preparation of hybridoma cells |
JPS59169489A (ja) * | 1983-03-15 | 1984-09-25 | Otsuka Pharmaceut Co Ltd | ヒト培養株化細胞 |
EP0131878A3 (de) * | 1983-07-19 | 1987-08-05 | Sloan-Kettering Institute For Cancer Research | Verfahren zur Herstellung menschlicher monoklonaler Antikörper |
DK172686A (da) * | 1985-04-22 | 1986-10-23 | Hybritech Inc | Antigen opnaaet ud fra humant vaev, fremgangsmaade til under anvendelse af antigenet at fremstille monoklonale antistoffer til diagnose og behandling af cancer, fremgangsmaade til paavisning af cancer, samt antistoffer mod antigenet |
-
1984
- 1984-11-20 US US06/673,370 patent/US4693975A/en not_active Expired - Fee Related
-
1985
- 1985-09-12 AT AT85306493T patent/ATE58554T1/de not_active IP Right Cessation
- 1985-09-12 DE DE8585306493T patent/DE3580654D1/de not_active Expired - Fee Related
- 1985-09-12 EP EP85306493A patent/EP0182467B1/de not_active Expired - Lifetime
- 1985-09-25 CA CA000491535A patent/CA1245581A/en not_active Expired
- 1985-10-02 JP JP60219985A patent/JPS61128886A/ja active Pending
- 1985-11-19 AU AU50078/85A patent/AU577745B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
JPS61128886A (ja) | 1986-06-16 |
EP0182467A2 (de) | 1986-05-28 |
DE3580654D1 (de) | 1991-01-03 |
AU577745B2 (en) | 1988-09-29 |
US4693975A (en) | 1987-09-15 |
EP0182467A3 (en) | 1987-09-16 |
EP0182467B1 (de) | 1990-11-22 |
CA1245581A (en) | 1988-11-29 |
AU5007885A (en) | 1986-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE58554T1 (de) | Menschlicher hybridomfusionspartner zur herstellung menschlicher monoklonaler antikoerper. | |
ATE26464T1 (de) | Rekombinante monoklonale antikoerper. | |
AU542303B2 (en) | Antibody production by rat myeloma cells | |
EP0176355A3 (de) | Immunologisches Verfahren unabhängig von Antigenen | |
JPS5673029A (en) | Production of antibody against hepatitis virus and cell system therefor | |
JPS5695123A (en) | Hybrid cell line* antibody and method for manufacturing monoclonal antibody to human prothymocyte cell | |
SE8300290D0 (sv) | Process for the production of human mono-clonal antibodies | |
EP0440266A3 (de) | Menschliche monoklonale Antikörper gegen bakterielle Toxine | |
PT86792A (pt) | Monoclonal antibodies against melanoma-associated antigens hybrid cell lines producing these antibodies and use therefor | |
SE8106528L (sv) | Framstellning av menskliga monoklonala antikroppar medelst menskliga hybridom | |
AU545181B2 (en) | Hybridoma for producing monoclonal antibodies | |
JPS5753411A (en) | Monoclonal antibody against drug, manufacture and somatic cell hybridoma for monoclonal antibody production | |
AU545222B2 (en) | Hybridoma for producing monoconal antibodies | |
DE3581288D1 (de) | Antileishmania monoklonale antikoerper, diese antikoerper ausscheidende hybridomas, von diesen antikoerpern erkannte leishmaniaantigene, verfahren zur herstellung und verwendung von diesen monoklonalen antikoerpern und antigenen. | |
EP0161638A3 (en) | Monoclonal antibody and method for quantitation of immoglobulins using the same | |
DE3485128D1 (de) | Zellinien verwendbar zur herstellung von hybridomazellen. | |
EP0102601A3 (de) | Monoklonaler Antikörper, Verfahren zu seiner Herstellung und Verwendung dieses monoklonalen Antikörpers | |
ES8503371A1 (es) | Procedimiento para preparar nuevos anticuerpos de igg de raton con especificidad anti-interferon de humano | |
DE3576359D1 (de) | Verfahren zur herstellung von tumorspezifische monoklonale antikoerper produzierenden hybridomazellen. | |
KR860007275A (ko) | 모노클로날 항-알파-아밀라제 항체 및 그의 제법 | |
ES8801945A1 (es) | Un procedimiento para la obtencion de anticuerpos monoclonales contra peptidos atriales natuureticos. | |
EP0287397A3 (en) | Monoclonal antibody specific to human pancreatic phospholipase a2 | |
DE3580524D1 (de) | Monoklonaler antikoerper geeignet zur spezifischen unterscheidung von humanen hepatokarzinomzellen. | |
ES8609465A1 (es) | Procedimiento para preparar nuevos anticuerpos monoclonales de raton con especificidad anti-interferon de humano | |
EP0287012A3 (de) | Monoklonaler Anti-R-Binder-Antikörper, Verfahren zu seiner Herstellung und seine Verwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |